Blue Ridge Bankshares: Discounted Valuation Is Justified By Fundamental Issues — Negative
BRBS Seeking Alpha — August 12, 2025Blue Ridge Bankshares faces regulatory constraints and lacks a competitive edge in the Virginia banking market, limiting its growth prospects. The bank is exiting its fintech partnerships after an OCC Consent Order, focusing on traditional community banking to reduce risk and improve controls. Despite strong capital ratios, Blue Ridge cannot pay dividends due to regulatory restrictions, and its earnings capacity has declined post-fintech exit.
Circle CEO Jeremy Allaire: We'll see robust credit markets on blockchain networks — Positive
CRCL CNBC Television — August 12, 2025Circle CEO Jeremy Allaire on Tuesday said he believes the rise of stablecoins won't crowd out lending, but rather that blockchain networks will develop "very robust credit markets."
BMO's Joel Jackson has a $125 price target on lithium miner Albemarle. Here's why — Positive
ALB CNBC Television — August 12, 2025Joel Jackson, BMO Capital Markets, joins 'Power Lunch' to discuss Jackson's optimism around Ablemarle, lithium price trends and much more.
Weis Markets: A Grocery Stock That's Hard To Justify In Your Cart — Positive
WMK Seeking Alpha — August 12, 2025Weis Markets remains a safe, steady, but uninspiring stock, delivering low-single-digit revenue growth and stable margins, but underperforming the S&P. Capital allocation continues to disappoint, with cash used for related-party share buybacks rather than rewarding minority shareholders through dividends or open-market repurchases. Q2 results showed resilient core grocery and pharmacy growth, but margin compression and higher costs weighed on profitability, with little near-term upside expected.
CoreWeave's Chart Looks Bullish — Earnings Could Be The Next Catalyst — Positive
CRWV Benzinga — August 12, 2025CoreWeave Inc CRWV has been riding a strong upward current this year, surging more than 250% year-to-date and steadily climbing through the summer months. Now, as it prepares to report second quarter earnings Tuesday, investors are eager to see if this cloud infrastructure leader can keep its bullish streak alive — or if some turbulence lies ahead.
'Clock Has Struck Midnight' on Apple's AI Strategy, Dan Ives — Negative
AAPL Bloomberg Markets and Finance — August 12, 2025Dan Ives, Global Head: Technology Research at Wedbush Securities, talks about his note on Apple trying to avoid its "Blackberry Moment." Apple's decision to delay its next-generation Siri features this year set off a storm inside the company, leading to executive changes and underscoring to the public just how far behind the company is in artificial intelligence.
CAVA Group Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call — Negative
CAVA Benzinga — August 12, 2025CAVA Group, Inc. CAVA will release earnings results for the second quarter, after the closing bell on Tuesday, Aug. 12.
Lumentum Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call — Neutral
LITE Benzinga — August 12, 2025Lumentum Holdings Inc. LITE will release earnings results for the fourth quarter, after the closing bell on Tuesday, Aug. 12.
Circle CEO Jeremy Allaire discusses the company's revenue growth and plans to build new products. Shares of the stablecoin issuer jumped following its first earnings report as a public company.
Circle Stock Pops On Q2 Earnings: USDC Hits $65.2 Billion In Mainstream Stablecoin Adoption — Positive
CRCL Benzinga — August 12, 2025Circle Internet Group, Inc. CRCL posted stand-out second-quarter financial results on Tuesday in its first earnings report as a publicly traded company.
Capital Increase in Genmab as a Result of Employee Warrant Exercise — Neutral
GMAB GlobeNewsWire — August 12, 2025Company Announcement COPENHAGEN, Denmark; August 12, 2025 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 4,563 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others.
Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet — Negative
VRTX Seeking Alpha — August 12, 2025A 20% drop in Vertex Pharmaceuticals' stock price since I wrote last month was the impetus to make a re-assessment. But the rating has remained unchanged at Hold. This is despite significantly improved Q2 2025 results, seen in both revenue and non-GAAP earnings' growth, with revenues supported by the likes of Alyftrek and Journavx,. However, an unchanged guidance and disappointing trial outcomes for its investigative pain relief treatment led to a price plunge.
White House says it's working out legality of Nvidia and AMD China chip deals — Negative
AMD NVDA CNBC — August 12, 2025The Trump administration is still working out the details of its 15% export tax on Nvidia and could bring deals of this kind to more companies, the White House said Tuesday. "Right now it stands with these two companies.
Cisco Earnings Preview: Stock Price Nearing Its April 2000 All-Time High — Positive
CSCO Seeking Alpha — August 12, 2025Analyst consensus is expecting $0.98 in earnings per share on $14.6 billion in revenue as well as 4.97 billion in operating income, for expected year-over-year (y-o-y) growth of 13%, 7% and 14% respectively. Cisco's last big acquisition, Splunk, will now be in Cisco's organic numbers with fiscal Q4 '25. In terms of AI, Cisco appears to have a relatively small AI offering for now, just $1 billion versus the $56–$59 billion in annual revenue, but the AI revenue did look to have beaten expectations in fiscal Q3 '25.
Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap — Positive
COR Seeking Alpha — August 12, 2025Cencora delivered strong quarterly results and guidance upgrades, but expectations need to be moderated as these results should fade in the coming quarters. The valuation remains elevated at 17.9x forward P/E, well above the 5-year average, making the risk/reward unattractive at current levels. Key risks include heavy revenue exposure to Walgreens Boots Alliance, which faces solvency issues and plans to sell its COR stake.
TJX to Report Q2 Earnings: Essential Insights Ahead of the Report — Positive
TJX Zacks Investment Research — August 12, 2025The TJX Companies rides rising shopper loyalty, strong apparel and home sales, and e-commerce gains, though higher costs and tariffs loom.
PDYN Incurs Q2 Loss Amid Revenue Drop, Contract Slowdown — Negative
PDYN Zacks Investment Research — August 12, 2025Palladyne AI incurs a loss in Q2 while its revenues plunge 63% year over year as the company increases investment in AI software commercialization and product development.
Moody's Reaffirms WSFS Financial Corp's Baa2 Issuer Rating with a Stable Outlook; Reflects Diversified Business Model, Strong Capital, and Earnings Strength — Neutral
WSFS Business Wire — August 12, 2025WILMINGTON, Del.--(BUSINESS WIRE)--Moody's Investors Service has reaffirmed their ratings to WSFS Financial Corporation (NASDAQ: WSFS) (“WSFS” or “the Company”) and WSFS Bank with issuer ratings of Baa2 with a stable outlook. Long-and short-term deposits of A2/Prime-1, together with a standalone Baseline Credit Assessment of Baa1. Moody's has also assigned Counterparty Risk Assessment of A3(cr)/Prime-2(cr) and Counterparty Risk Ratings (local and foreign currency) of Baa1/Prime-2. Moody's debt.
Cardinal Health's multi-specialty management services organization (MSO), The Specialty Alliance, plans to acquire urology MSO Solaris Health. Cardinal Health will enable the acquisition by providing about $1.9 billion in cash to The Specialty Alliance and will own about 75% of The Specialty Alliance after the acquisition of Solaris Health, Cardinal Health said in a Tuesday (Aug.
Should You Buy, Sell or Hold MP Stock Post Q2 Earnings Beat? — Positive
MP Zacks Investment Research — August 12, 2025MP Materials posts record NdPr output, 84% revenue surge and lands landmark Apple and DoD deals, fueling strong growth prospects.